SUMMARY The review focuses on the last decade of research regarding the use of various oral appliances (OAs) in the management of sleep bruxism (SB) in adults. Sixteen (n = 16) papers of 641 identified citations involving 398 participants were included in the review. Of them, seven were randomised controlled trials (RCTs), seven were uncontrolled before-after studies and two were crossover trials. Analysis of the included articles revealed a high variability of study designs and findings. Generally, the risk of bias was lowto-unclear for RCTs and high for crossover studies, whilst the before-after studies exhibited several structural limitations. Nine studies used polysomnography/polygraphy/electromyography for SB diagnosis, whilst others were based on history taking and clinical examination. Most of them featured small samples and were short term. Of the studies using objective SB evaluations, eight showed positive results for almost every type of OA in reducing SB activity, with a higher decrease for devices that are designed to provide a certain extent of mandibular advancement. Among the studies using a subjective SB evaluation, one demonstrated a significant reduction in SB activity, and additional two showed a myorelaxant effect of OA in SB patients. Although many positive studies support the efficiency of OA treatment for SB, accepted evidence is insufficient to support its role in the long-term reduction of SB activity. Further studies with larger samples and sufficient treatment periods are needed to obtain more acknowledgements for clinical application.
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KEYWORDS: humans, management, movement disorder, occlusal splints, sleep bruxism, tooth grinding Accepted for publication 24 August 2017 Background Sleep bruxism (SB) is a recurrent rhythmic activation of masticatory muscles, characterised by clenching and/or grinding of the teeth and/or by bracing or thrusting of the mandible during sleep (1) . Particularly, SB is now considered a behaviour that may lead to harm, with a yet to be determined multifactorial aetiology involving a complex of multisystem physiological processes (2, 3) . In connection with aetiology, a recent systematic review of the risk factors for SB concluded that the history of SB during childhood, gastroesophageal reflux disease and genetic polymorphisms seem to be strongly associated with SB in adults (4) . In a recent survey (5), SB was reported to occur regularly in 8Á6% and on occasion in 13Á7% of the general population. No gender differences for SB were reported. Another study has found a non-significant reduction in the frequency of SB with age (6) . According to the current concept, a certain amount of bruxism-related motor activities is not essentially pathological (2) . From a clinician's approach, SB should be viewed as a condition that requires management only when it has clinical consequences for the stomatognathic system (3) (e.g. abnormal tooth wear, temporomandibular joint [TMJ] and/or masticatory muscle pain, headaches, complications in prosthodontic rehabilitation that have been systematically reviewed over the past few years (7) (8) (9) ).
It is recommendable that SB treatment is cautiously provided within the framework of a multiple approach design (i.e. oral appliances [OAs] , centrally acting drugs, counselling/behavioural strategies, psychological treatment, physiotherapy) (10) . Unfortunately, current evidence does not support a standard of reference approach for SB treatment, except for the use of OA (10) , which minimises damage to the teeth, yet do not actually prevent or stop SB (11) . The term 'oral appliance' covers a wide variety of devices (including simple appliances that cover an entire or a part of the dental arch or those providing a certain extent of mandibular advancement) which are available with different design features and materials as far as various functional abilities are concerned. A 2007 review performed by Macedo et al. (12) . pointed out that the use of occlusal splint (OS) itself is questionable with regard to the sleep outcomes, but some benefit may exist with regard to tooth wear. Therefore, authors also suggested recommendations for designing higher quality studies.
Despite other promising treatments such as clonidine (13) and contingent electrical stimulation (14) that have been associated with a reduction in SB motor activity, OAs remain the most commonly applied treatment of SB. Thus, following a decade of expanded research, knowledge on bruxism has likely been improved, and new evidence on the role of various OA in managing patients with SB has been provided. Based on that, the aim of this study was to clarify whether there is any benefit from various currently available OA in the management of SB, by assessing a decade of studies on the topic.
Materials and methods

Protocol and registration
The protocol for this systematic review (CRD42016045894) was registered in the International prospective register of systematic reviews (https://www.crd.york.ac.uk/PROSPERO/).
The reporting of this systematic analysis adhered to the PRISMA (Preferred Reporting Item for Systematic Review and Meta-Analyses) Statement (15) .
Focused question
The following focused question was developed according to the population, intervention, comparison and outcome (PICO) study design: What is the effect of OA on various treatment outcomes in adult patients with SB?
Search strategy
On 25 January 2017, a systematic search in the medical literature was performed to identify all peerreviewed papers investigating the efficiency of any type of OA on SB. The search strategy incorporated detailed individual examinations of the Cochrane Library (Cochrane Central Register of Controlled Trials) and MEDLINE (searched via PubMed) databases. The keywords that were used during the primary search stage in PubMed and adapted to the other database were as follows: ('Bruxism' OR 'Grinding') AND ('Splint' OR 'Guard' OR 'Device' OR 'Appliance'). The search was expanded by checking for potential additional papers in the reference lists of relevant papers. Articles written in the English language were only considered for inclusion. The literature search was limited to papers that were added to the databases between January 2007 and January 2017.
All identified electronic database citations were managed by online bibliographic management program (RefWorks, ProQuest), and duplicate hits were removed. Based on the title and abstract screening, the studies were selected for potential inclusion independently by two review authors (L.J., A.B.), who also performed data extraction and quality assessment after reading the full texts to confirm each study's eligibility. Reviewers compared decisions and resolved disagreements through discussion, consulting a third reviewer (G.P.) when consensus could not be reached.
Selection criteria
The criteria for admittance in the systematic review were based on the type of study and its model for clinical question (structural features). The inclusion was restricted to clinical investigations on humans, assessing the efficacy of any OA used for the control of SB in adult patients, as diagnosed with polysomnography (PSG) with or without audio-video (AV) recordings, polygraphy, nocturnal 
Quality assessment
The methodological quality of included randomised controlled trials (RCTs) was assessed using the criteria described in the Cochrane Handbook for Systematic Reviews of Interventions 5Á1Á0 (16) . Quality of the included before-after studies was assessed using the Critical Appraisal Skills Programme (CASP) Cohort Study Checklist (17).
Checklist for evaluation of crossover studies summarised from the Cochrane Collaboration's tool for assessing risk of bias and the Cochrane Handbook's suggestions for assessing risk of bias in crossover studies (18) was used.
Data extraction
Characteristics of the selected papers were summarised using a customised form of the following items: author and year of publication, demographic features of the sample and the sample size, description of intervention and control, method of assessing SB, and main outcomes. In addition, publications considered to present a higher level of evidence, that is RCTs and crossover studies, and studies of lower evidentiary strength, that is before-after studies, were arranged into two separate tables.
Synthesis of results
A narrative synthesis of results was performed. No meta-analysis could be performed due to the heterogeneity between the studies (different study designs, demographic features, intervention details, outcome measures and observation periods).
Results
Study selection
The initial search identified a total of 641 articles (Fig. 1) , of which 318 were retrieved for more detailed evaluation after the activation of additional database filters and removal of duplicates. After excluding the citations that were clearly not pertinent for the review's aim on the basis of their title and abstract, 32 papers were retrieved in full text. The selection criteria were applied to the full-text articles in order to reach consensus as to include/exclude the papers for/from systematic assessment. The decision was to exclude 16 of 32 papers (reasons are provided in Fig. 1 ). Thus, the search process returned 16 relevant publications, which were included in the systematic review. Of them, seven were RCTs (19) (20) (21) (22) (23) (24) (25) , seven were uncontrolled before-after studies (26) (27) (28) (29) (30) (31) (32) , and two were crossover trials (33, 34) .
Quality assessment
Quality assessment of RCTs demonstrated that, on average, the risk of bias was low-to-unclear for all the included studies (Table 1) . It was mostly related to the unclear report of blinding of participants and personnel (71Á4%), as well as with the unclear report of allocation concealment (42Á8%) and blinding of outcome evaluations (28Á5%). Other potential risks of bias were related to the clinical-only SB diagnosis that was adopted in 57Á1% of studies, the use of diurnal EMG alone for masticatory muscle activity measurement (28Á6%) and the non-use of PSG or EMG to measure SB activity (28Á6%). The impact of such sources of risk has been judged as 'unclear'.
Quality assessment of the before-after studies revealed several methodological limitations, mainly due to the adoption of very small-sized study samples, failure to include multiple observation points, also due to unclear implications for practice and outcome measure methods (Table 2) .
Quality assessment of the included crossover studies showed a high risk of bias (Table 3) . Mainly it was related to the absence of washout periods and unclear
report of potential carry-over effect, allocation concealment and blinding.
Interventions
Sixteen studies report on the effectiveness of OA (Tables 4 and 5 ). Four studies (28, 29, 31, 32) investigated the effect of OS alone; three studies (26, 27, 30) concerned the effect of mandibular advancement appliance (MAA); two studies (21, 34) compared OS with different configurations of the MAA; one study (19) investigated the effect of intermittent versus continuous use of OS; remaining studies included comparison groups treated with nociceptive trigeminal inhibition (NTI) splint (20) , with biofeedback (22) and cognitive behavioural (CBT) therapy (25) , with massage (23), with gabapentin (24) and with different design appliances (33) . All types of appliances are described in Table S1 .
Participants
All studies included 398 adult patients in total. Nine studies confirmed SB by means of PSG/polygraphy/ sleep-time EMG (objective evaluation), whilst the other seven were based on history taking and clinical examination (subjective evaluation). Five of these studies used diurnal EMG records to measure changes in masticatory muscle activity, one study was based on the abrasion degree of a bite plate-like device, and the last one relied on a mini device analysing bite force. Participants with comorbidity (temporomandibular disorders [TMD]) were observed in three studies (23, 29, 32) .
Duration
Observation period varies across studies, ranging from 1 night to up to 3 months. Observation points are multiple, viz., more than only the baseline and end of treatment assessments, in five studies only (19, 21, 22, 25, 26) .
Study outcomes
The included investigations compared different OA designs and treatment regimens. Studies, which were based on an objective SB evaluation, demonstrated that an intermittent use of OS was superior to continuous wearing (19); OS does not significantly inhibit masseter muscle motor activity during sleep, yet it may increase slow wave sleep (28); most SB variables significantly decreased after treatment with the OS, as well as in the gabapentin control group (24); restriction of mandibular movements with OA does not have any major influence on jaw muscle activity during sleep (33) ; MAA provides greater reduction in SB episodes compared to OS (21, 34) (whereas 75% advancement position is superior to 25% position (34) ); the use of MAA (50%-75%) produces a significant improvement in both SB and sleep quality (26, 27, 30) , however, it may cause pain in muscles and TMJ (27) .
Studies, that employed a subjective SB evaluation, indicate that OS may have a myorelaxant effect on patients with stress-related SB (29, 31) ; SB activity is not significantly affected by OS, but it may decrease signs and symptoms of TMD (32); neither OS nor NTI splint showed any significant influence on the examined masticatory muscles (20) ; the use of an OS had no significant influence on EMG activity of the masseter and temporal muscles compared with baseline and other treatment groups (23) ; in contrast to biofeedback, OS alone did not significantly reduce SB activity after treatment (22) ; both the OS and the CBT groups showed a significant reduction in SB activity compared with baseline, yet the effects were small, and no differences between groups were seen (25). Table 1 . Quality assessment of randomised controlled trials (RCTs) based on the cochrane handbook of systematic reviews of interventions (16) 
Discussion
The present review evaluated the existing literature related to the efficiency of various OA in the management of SB in an adult population. It is important to note that inclusion in the review was open not only to RCTs but also to before-after studies. Among the papers identified during the search process, 16 satisfied the inclusion criteria and were thus included. In general, the methodological quality of the seven RCTs included was acceptable, although there were some areas with potential risk of bias. Most studies did not give a clear description of blinding of participants and personnel, and the concealment of allocation. As for crossover trials, mainly the absence of washout periods resulted in a high risk of bias. Quality limitations of before-after studies were generally associated with the small samples. Considering the clinical significance of the selected papers, it should be highlighted that, with reference to the diagnostic classification proposed by Lobbezoo et al. (35) . in 2013, only six studies were based on a definite diagnosis of SB (i.e. PSG), and three relied on its best available alternative (i.e. sleep-time EMG). The remaining studies were rather based on a possible or probable rating (i.e. selfreport and clinical investigations). In addition, the use of other SB measurement methods rather than PSG or sleep-time EMG may have influenced the results of several studies.
In this systematic review, we found that types of OA interventions, control, observation periods and outcome indices were too diverse and confusing. Consequently, the absence of between-study homogeneity prevented us from performing a meta-analysis. Thus, the reliability of the findings, although significant, should be evaluated with caution. Within these limitations, the present review provides clinical important findings related to the role of OA in the management of SB.
Two of the included studies analysed the EMG signs of masseter and temporalis muscles in women and reported a significant reduction in EMG activity after sleep, reportedly after one night (29) and at least 30 days of use (31) of the OS in patients with SB related to stress. Yet, factors such as rest resulting from sleep, an absence of stress environment and short observation clearly may have influenced the results. However, the EMG evaluation of masseter and temporalis muscles in people with SB, being treated with OS for a longer period, did not present a significant difference before and after treatment (2 papers) (23, 32) . A major bias of these included studies is that they are not sleep studies with nocturnal EMG recordings, and no changes of SB were observed during treatment. Similarly, a study by Harada et al. (36) . has not found a significant reduction in masseter EMG activity after 6 weeks of treatment with OS and palatal device; however, there was a significant difference immediately after insertion of splints. Gu et al. (22) . evaluated the efficacy of biofeedback therapy contrasted with OS and demonstrated indefinite results after using a miniature OS for 12 weeks, which did not reach statistical significance compared with the biofeedback group. However, it was a pilot study which measured SB using an intra-oral device based on bite force. In contrast, two of the included Table 3 . Quality assessment of crossover trials based on quality assessment standard for crossover studies (18 Bite plate-like device measuring abrasion degree Significant reduction in SB activity, self-assessment of SB activity and psychological impairment, as well as an increase of positive stress-coping strategies in both groups. The effects were small, and no between-group differences were seen I, intervention; C, comparison; M, male; F, female; m.a., mean age; OS, occlusal splint; NTI, nociceptive trigeminal inhibition splint; MAA, mandibular advancement appliance; PSG, polysomnography; AV, audio-video recordings; PSQI, Pittsburgh sleep quality index; EMG, electromyography; CBT, cognitive behaviour therapy; OAs, oral appliance; SB, sleep bruxism; TMD, temporomandibular disorders. 
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PSG studies compared OS with gabapentin (24) and MAA (21) and reported a significant reduction in SB episodes after a 2-month, and a 3-month treatment period with OS, respectively. However, due to the small sample sizes, findings must be interpreted with caution. Additionally, studies were performed over a short period, while a previous study reported that in some patients a reduction in SB motor activity can persist up to 6 months (37). Ommerborn et al. (25) . found a small but significant reduction in SB activity after a 12-week treatment with OS and a 6-month follow-up compared with the CBT group, yet did not detect SB activity by means of EMG or PSG, which was a major methodological flaw. Therapeutic mechanisms of OS are not yet entirely clarified, although suggestions were made that it can eliminate occlusal interferences and re-establish symmetric and reduced postural activity in the temporal and masseter muscles (38, 39) . However, one included study compared the OS and NTI groups and observed no changes in terms of normalised muscle activity after treatment (20) . Authors suggested a need for quantitative measurement of the treatment quality. Other studies report that changes in the input feedback mechanism of peripheral oral receptors after the use of OA may temporarily diminish SB (40, 41) , yet the effect is not maintained due to the adaptive mechanisms of the stomatognathic system. This theory would explain a clinical finding that the intermittent use of OA may reduce SB activity for a longer period than that of continuous use (one paper) (19) . In addition, one included paper investigated the effect of restriction of mandibular movements during sleep with different types of OA and also concluded that the immediate effect of any combination of OA causes a suppression in EMG activity (33) . However, a small sample size and the short duration of the treatment phases are two major weaknesses of this crossover study. Other potential affecting factors may include placebo effect, alteration of the condylar position, increase in the vertical dimension on the occlusal surface and cognitive awareness (28) . Furthermore, OA can protect the teeth from excessive wear in the case of heavy SB (28) .
Several included observations suggest that in some patients OS treatment may increase SB-related oromotor activity, while others may experience a decrease or even no change in it (28, 34) . This individual variation was also observed in the previous studies (42, 43) . It has been reported that the use of thick maxillary OS may increase the severity of the respiratory disturbance index in patients with obstructive sleep apnoea (OSA) (44, 45) . Respiratory disturbances may enhance arousals and provoke SB activity (46, 47) . Other sleep disturbances might as well increase arousals and provoke SB activity as a secondary phenomenon in a group of bruxists (48) . These findings might explain the observed variations in SB activity. However, the mechanisms of OA functioning and its effect on SB are yet to be explored in detail.
Several included studies suggest that OS therapy may improve sleep quality (21, 28) , however, one study did not report this improvement (24) , which is in line with the previous findings in the literature (49) . The increase of slow wave sleep and sleep quality might have occurred due to the use of superior anterior positioning splint and improved airflow in the study by Sjoholm et al. (28) , although additional studies are needed to clarify the exact mechanism.
Moreover, a combination of massage and OS therapies showed an improved intensity of TMD signs and symptoms (one paper) (23) (measured through the Helkimo index), likewise, the use of OS alone also helped decrease them (one paper) (32) (measured 
through the Fonseca Patient History Index). However, none of the studies found significant differences in EMG records after treatment. A similar study by Holmgren et al. (50) . observed a great reduction in symptoms of TMD after a 6-month treatment with OS, although SB behaviour persisted. Indeed, an OS may contribute to reducing myofascial pain (51) , improving the quality of life (52) and increasing maximum mouth opening (53), although it does not cure TMD (23) . It was found that OAs that are designed to provide a certain extent of mandible advancement are effective in reducing SB (5 papers) (21, 26, 27, 30, 34) . Moreover, results show that MAA originally used for the treatment of OSA produce a greater reduction in SB scores than OS (2 papers) (21, 34) . The mechanism of action of a MAA is still unclear, although there are theories that may explain such findings. In previous studies (38) (39) (40) , muscle pain and discomfort have been associated with a decrease in oromotor activities. A high number of subjects reported pain with the MAA (50%-75% protrusion) that possibly prevented the occurrence of SB episodes (4 papers) (21, 26, 27, 34) . However, it appears that MAA with a minimum protrusion of 25% significantly reduces SB without creating discomfort, indicating that more complex mechanism exists (one paper) (34) . Another theory may explain this improvement by the forward placement of the mandible and the maintenance of a more patent airway, which reduces apnoea-induced microarousals and eliminates SB motor activity (41, 42) ; however, further studies are needed to clarify this association (43) . Mandibular advancement appliance may also reduce the occlusal force in subjects with SB (2 papers) (26, 27) , probably due to the relaxation of strained masseter muscles while the mandible is advanced (30, 44) .
Nevertheless, treatment with MAA caused complications in a number of included studies. The latter included muscular and TMJ discomfort (21, 27, 30) or pain (26, 27) , tooth sensitivity, uncomfortable sensation and drooling (34) . Mandibular advancement appliance was reported to be associated with skeletal and occlusal side effects (54), however, no occlusal alterations were noticed in the included studies after its use, which was most likely due to the very short follow-up time (21, 27, 30) . Furthermore, participants showed a significant improvement in sleep quality (3 papers) (21, 26, 27) , which might be attributed to the airway patency, which leads to a reduction in microarousals, allowing deeper stages of sleep and reduction in SB activity (55) . The use of the MAA produced a significant reduction in TMJ sounds (2 papers) (27, 30) , which might be explained by the use of resilient material, which may reduce the load transmitted to the TMJs (27) . However, these findings need to be further investigated.
Finally, a distinct estimation of the effect on SB, dependent on the type of device, could not be made due to the inconsistent research data. This review revealed the need for well-conducted studies, with a strict methodological design and uniform outcome indices, as differences in between-study prevented us from performing any meta-analysis of data. Sufficient treatment period with repetitive analyses and larger samples should also be of concern. However, the use of PSG on large samples is slightly problematic due to its high cost and laboratory setting. Nevertheless, portable instrumental devices for diagnosing SB have been presented in the past and validated in PSG studies (56) (57) (58) (59) . Furthermore, these devices represent the most costeffective way for assessing SB in large sample studies (60) . Thus future studies designed to measure the effect of OA on SB activity could refer to those devices.
Conclusions
Although many positive studies support the efficiency of OA treatment for SB, accepted evidence is insufficient to support its role in the long-term reduction of SB activity. Notwithstanding, OA may much more contribute to the protection of natural teeth. Even if the evidence from the included studies was clinically relevant, further studies with larger samples and sufficient treatment periods are needed to obtain more acknowledgements for clinical application.
